Cannara Biotech Inc (LOVE.V)
0.81
+0.01
(+1.25%)
CAD |
TSXV |
May 17, 16:00
Cannara Biotech Cash from Operations (TTM): 8.064M for Feb. 29, 2024
Cash from Operations (TTM) Chart
Historical Cash from Operations (TTM) Data
| Date | Value |
|---|---|
| February 29, 2024 | 8.064M |
| November 30, 2023 | 6.106M |
| August 31, 2023 | 5.437M |
| May 31, 2023 | -0.5548M |
| February 28, 2023 | -4.805M |
| November 30, 2022 | -6.507M |
| August 31, 2022 | -6.079M |
| May 31, 2022 | -1.527M |
| February 28, 2022 | 1.692M |
| November 30, 2021 | 1.512M |
| Date | Value |
|---|---|
| August 31, 2021 | -2.093M |
| May 31, 2021 | -5.951M |
| February 28, 2021 | -9.511M |
| November 30, 2020 | -9.432M |
| August 31, 2020 | -9.325M |
| May 31, 2020 | -7.926M |
| February 29, 2020 | -8.571M |
| November 30, 2019 | -9.151M |
| August 31, 2019 | -7.409M |
Cash From Operations Definition
Cash flow from operations is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall operating activities of the company. A few examples of operating activities include change in receivables, change in inventories, and changes in current assets.
Cash from Operations (TTM) Range, Past 5 Years
-9.511M
Minimum
Feb 2021
8.064M
Maximum
Feb 2024
-3.475M
Average
-5.951M
Median
May 2021
Cash from Operations (TTM) Benchmarks
| Biocure Technology Inc | -0.2171M |
| Core One Labs Inc | -- |
| Nova Mentis Life Science Corp | -- |
| Nanosphere Health Sciences Inc | -0.0725M |
| Lobe Sciences Ltd | -1.746M |